Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Top Ten Searches
gynecomastia empyema henoch–schönlein otitis media dyspnea jaundice ventricle lyme immunodeficiency coolingYour Article Summary
Successful Management of Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon Using Vincristine and Ticlopidine
Pediatric Dermatology, 06/26/09
Lopez V et al. - Kaposiform hemangioendothelioma is a rare locally aggressive vascular tumor that usually occurs in skin and retroperitoneum of infants and young children. The authors present a case of a newborn with a rapid tumor growth and a life-threatening Kasabach-Merritt syndrome with a progressive remission after treatment with vincristine and ticlopidine.
Related Articles
Kaposiform hemangioendothelioma ,rare case report
Journal of Research in Medical Sciences, 11/02/09
Relevance Score: 67%
Lenalidomide stops progression of multifocal epithelioid hemangioendothelioma including intracranial disease
Journal of Neuro-Oncology, 11/18/09
Relevance Score: 41%
Treatment of Hepatic Epithelioid Hemangioendothelioma
Archives of Surgery, 11/17/09
Relevance Score: 41%
Today in Pediatric Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Incidence and Correlates of Radiation Dermatitis in Children and Adolescents Receiving Radiation Therapy for the Treatment of Paediatric Sarcomas
Clinical Oncology, 11/12/09
Effectiveness of No-Sting skin protectant and Aquaphor on water loss and skin integrity in premature infants
Journal of Perinatology, 11/10/09
An inverse association between history of childhood eczema and subsequent risk of type 1 diabetes that is not likely to be explained by HLA-DQ, PTPN22, or CTLA4 polymorphisms
Pediatric Diabetes, 11/06/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


